CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to add... CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. 詳細を表示
MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43rd...
MINNEAPOLIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Piper...
MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.35 | 11.0024449878 | 12.27 | 13.68 | 11.3853 | 182344 | 12.15777169 | CS |
4 | -1.67 | -10.9221713538 | 15.29 | 15.64 | 11.3853 | 169615 | 13.45860894 | CS |
12 | 4.93 | 56.7318757192 | 8.69 | 16.015 | 6.79 | 299042 | 12.4986799 | CS |
26 | 3.17 | 30.3349282297 | 10.45 | 16.015 | 6.75 | 306511 | 10.51859154 | CS |
52 | -11.38 | -45.52 | 25 | 33.135 | 6.4 | 268252 | 12.65794288 | CS |
156 | 1.49 | 12.2835943941 | 12.13 | 33.135 | 4.6 | 179043 | 12.14273984 | CS |
260 | -12.63 | -48.1142857143 | 26.25 | 33.135 | 4.6 | 173165 | 12.84965029 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約